1. Academic Validation
  2. CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling

CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling

  • Sci Signal. 2018 Jul 31;11(541):eaam8216. doi: 10.1126/scisignal.aam8216.
Kate L Henry 1 2 Debra Kellner 1 Bekim Bajrami 1 John E Anderson 1 2 Mercedes Beyna 1 Govinda Bhisetti 1 Tom Cameron 1 Andrew G Capacci 1 Andrea Bertolotti-Ciarlet 1 Jun Feng 1 Benbo Gao 1 Brian Hopkins 1 Tracy Jenkins 1 Kejie Li 1 Tricia May-Dracka 1 Paramasivam Murugan 1 Ru Wei 1 Weike Zeng 1 Norm Allaire 1 Alan Buckler 1 Christine Loh 1 Peter Juhasz 1 Brian Lucas 1 Katelin A Ennis 1 Elisabeth Vollman 1 Ellen Cahir-McFarland 1 Erik C Hett 3 Michelle L Ols 1
Affiliations

Affiliations

  • 1 Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
  • 2 Department of Pharmacology, Boston University School of Medicine, Boston, MA 02118, USA.
  • 3 Biogen, 225 Binney Street, Cambridge, MA 02142, USA. erikhett@gmail.com.
Abstract

Members of the family of nuclear factor κB (NF-κB) transcription factors are critical for multiple cellular processes, including regulating innate and adaptive immune responses, cell proliferation, and cell survival. Canonical NF-κB complexes are retained in the cytoplasm by the inhibitory protein IκBα, whereas noncanonical NF-κB complexes are retained by p100. Although activation of canonical NF-κB signaling through the IκBα kinase complex is well studied, few regulators of the NF-κB-inducing kinase (NIK)-dependent processing of noncanonical p100 to p52 and the subsequent nuclear translocation of p52 have been identified. We discovered a role for cyclin-dependent kinase 12 (CDK12) in transcriptionally regulating the noncanonical NF-κB pathway. High-content phenotypic screening identified the compound 919278 as a specific inhibitor of the Lymphotoxin β Receptor (LTβR), and tumor necrosis factor (TNF) receptor superfamily member 12A (FN14)-dependent nuclear translocation of p52, but not of the TNF-α receptor-mediated nuclear translocation of p65. Chemoproteomics identified CDK12 as the target of 919278. CDK12 inhibition by 919278, the CDK Inhibitor THZ1, or siRNA-mediated knockdown resulted in similar global transcriptional changes and prevented the LTβR- and FN14-dependent expression of MAP3K14 (which encodes NIK) as well as NIK accumulation by reducing phosphorylation of the carboxyl-terminal domain of RNA polymerase II. By coupling a phenotypic screen with chemoproteomics, we identified a pathway for the activation of the noncanonical NF-κB pathway that could serve as a therapeutic target in autoimmunity and Cancer.

Figures
Products